Your Yourlocation: Home > Tiotropium bromide(136310-93-5) is safe and effective in patients with COPD

Patients receiving LABAs benefit greatly from the use of airflow limiting measures, health-related quality of life and the use of first aid medications. Compared with LABAs, tiotropium bromide(136310-93-5) was associated with a reduction in severe COPD recurrence (RR = 0.52; 95% CI 0.31 - 0.87).

"This systematic review supports the use of LABAs for patients with moderate to severe COPD and does not support the conclusion that previous LABAs increase the risk of respiratory death," according to the authors. "Our analysis also suggests that for patients with stable COPD, "The limitations of this systematic review are that only 39% of respiratory deaths occur in the sample, and 18 of the 27 studies were combined with inhaled steroids in the LABAs and placebo groups.

A review, published at the same time, suggests that therapeutic approaches are needed to find the most effective regimen for individualized COPD patients for optimal treatment.

"If patients with COPD have been meticulously treated for pulmonary function tests and confirmed that they do not have asthma, tiotropium bromide(136310-93-5) bromide is the most appropriate first-line drug," Dr. Sears writes. "LABAs are used in combination with inhaled steroids instead of alone Is a suitable second choice. "

"Since LABAs alone are as safe as placebo, the combination of LABAs and inhaled steroids appears to be better than single use.In summary, daily tiotropium bromide(136310-93-5) is the basic drug for long-acting bronchodilators in COPD, In spite of this, the ambiguities in the current COPD guidelines are somewhat ambiguous. "

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved